[{"AccountsPayableCurrent":1597800000.0,"AccountsReceivableNetCurrent":5829400000.0,"AccruedIncomeTaxesNoncurrent":3738000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment":9842200000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax":-6287100000.0,"AdditionalPaidInCapitalCommonStock":6669200000.0,"AllowanceForDoubtfulAccountsReceivableCurrent":23900000.0,"Assets":47809000000.0,"AssetsCurrent":17295500000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax":14500000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax":2900000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue":128100000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue":163900000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue":189300000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue":21600000.0,"AvailableForSaleSecuritiesDebtSecurities":502900000.0,"AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureOtherPercentageOfNonperformingAssets":0.98,"CashAndCashEquivalentsAtCarryingValue":3220000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations":3220000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":-437100000.0,"CommitmentsAndContingencies":null,"CommonStockDividendsPerShareDeclared":1.7,"CommonStockSharesHeldInEmployeeTrust":3013200000.0,"CommonStockValue":598100000.0,"ComprehensiveIncomeNetOfTax":1498700000.0,"ContractWithCustomerLiability":270900000.0,"CostOfGoodsAndServicesSold":1953200000.0,"DebtCurrent":1778500000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition":164800000.0,"DeferredIncomeTaxAssetsNet":2674900000.0,"DeferredIncomeTaxLiabilitiesNet":1857300000.0,"DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear":10000000.0,"DepreciationDepletionAndAmortization":719600000.0,"DividendsPayableCurrent":770800000.0,"EarningsPerShareBasic":1.53,"EarningsPerShareDiluted":1.53,"EffectiveIncomeTaxRateContinuingOperations":0.128,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":-1600000.0,"EmployeeRelatedLiabilitiesCurrent":755500000.0,"EquitySecuritiesFvNiGainLoss":215400000.0,"FairValueInvestmentsEntitiesThatCalculateNetAssetValuePerShareUnfundedCommittments":758000000.0,"GainLossOnInvestments":518100000.0,"Goodwill":3884200000.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill":108100000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest":1593900000.0,"IncomeTaxExpenseBenefit":203700000.0,"IncreaseDecreaseInDeferredIncomeTaxes":413800000.0,"IncreaseDecreaseInOtherOperatingCapitalNet":-118400000.0,"IntangibleAssetsNetExcludingGoodwill":7985400000.0,"InterestExpense":86900000.0,"InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet":-17000000.0,"InventoryNet":3824900000.0,"InventoryWriteDown":423000000.0,"InvestmentIncomeInterest":5400000.0,"LiabilitiesAndStockholdersEquity":47809000000.0,"LiabilitiesCurrent":15093200000.0,"LiabilitiesNoncurrent":26052300000.0,"LongTermDebtNoncurrent":14736600000.0,"LongTermInvestments":3474900000.0,"MinorityInterest":219100000.0,"NetCashProvidedByUsedInFinancingActivities":-2141600000.0,"NetCashProvidedByUsedInInvestingActivities":-1766800000.0,"NetCashProvidedByUsedInOperatingActivities":3472900000.0,"NetIncomeLoss":2745500000.0,"NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent":-71100000.0,"NonoperatingIncomeExpense":511600000.0,"OtherAssetsNoncurrent":3638600000.0,"OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax":18400000.0,"OtherComprehensiveIncomeLossNetOfTax":108500000.0,"OtherComprehensiveIncomeLossTax":7900000.0,"OtherLiabilitiesCurrent":2624900000.0,"OtherLiabilitiesNoncurrent":1801900000.0,"OtherNonoperatingIncomeExpense":-14500000.0,"OtherOperatingActivitiesCashFlowStatement":319600000.0,"OtherReceivablesNetCurrent":1073400000.0,"PaymentsForProceedsFromOtherInvestingActivities":-50500000.0,"PaymentsForRepurchaseOfCommonStock":500000000.0,"PaymentsOfDividends":1543100000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired":747400000.0,"PaymentsToAcquireIntangibleAssets":25000000.0,"PaymentsToAcquireLongtermInvestments":503100000.0,"PaymentsToAcquireProductiveAssets":681600000.0,"PaymentsToAcquireShortTermInvestments":26600000.0,"PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent":3918500000.0,"PensionContributions":20000000.0,"PrepaidExpenseCurrent":3296600000.0,"ProceedsFromIssuanceOfLongTermDebt":0.0,"ProceedsFromPaymentsForOtherFinancingActivities":-294800000.0,"ProceedsFromSaleOfLongtermInvestments":461900000.0,"ProceedsFromSaleOfShortTermInvestments":21300000.0,"ProceedsFromShortTermDebt":196300000.0,"ProfitLoss":2745500000.0,"PropertyPlantAndEquipmentNet":8855500000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax":-90100000.0,"RepaymentsOfLongTermDebt":0.0,"ResearchAndDevelopmentExpense":1672800000.0,"RestructuringSettlementAndImpairmentProvisions":0.0,"RetainedEarningsAccumulatedDeficit":8530100000.0,"Revenues":6740100000.0,"SellingGeneralAndAdministrativeExpense":1685700000.0,"SeveranceCosts1":11500000.0,"ShareBasedCompensation":177400000.0,"ShortTermInvestments":51200000.0,"StockholdersEquity":6444400000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest":6663500000.0,"StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1":500000000.0,"TaxesPayableCurrent":529900000.0,"TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized":694300000.0,"TranslationAdjustmentForNetInvestmentHedgeNetOfTax":4360000000.0,"TreasuryStockSharesAcquired":0.0,"TreasuryStockValue":52700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding":910400000.0,"WeightedAverageNumberOfSharesOutstandingBasic":907300000.0,"AcquiredInProcessResearchAndDevelopment":25000000.0,"AssetImpairmentChargesRecoveriesAndOtherSpecialCharges":200100000.0,"AvailableforSaleSecuritiesandEquitySecuritiesFVNIRealizedGain":700000.0,"AvailableforsaleSecuritiesandEquitySecuritiesFVNIRealizedLoss":400000.0,"CostOfSalesOperatingExpensesAndOtherNet":5146200000.0,"DebtSecuritiesAvailableforsaleUnrealizedGainPosition":338100000.0,"DerivativeInstrumentsGainLossRecognized":92400000.0,"DescriptionOfDerivativeActivityVolumePercent":0.13,"LossContingencyNumberOfRequestsForInformation":2.0,"PaymentforPensionBenefitsAdditionalDiscretionaryFunding":10000000.0,"ProceedsfromSaleofEquityandAvailableforSaleSecurities":44400000.0,"PurchasedInProcessResearchAndDevelopment":341800000.0,"SalesRebatesAndDiscounts":7035800000.0,"ddate":20210630,"qtrs":0,"uom":"USD","footnote":null,"form":"10-Q","period":20210630.0,"fy":2021.0,"fp":"Q2","Symbol":"LLY","GICS Sector":"Health Care","GICS Sub-Industry":"Pharmaceuticals"}]